147 related articles for article (PubMed ID: 23333419)
1. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.
Dammermann W; Polywka S; Dettmann I; Mindorf S; Komorowski L; Wehmeyer M; Schulze Zur Wiesch J; Stöcker W; Lüth S
Med Microbiol Immunol; 2017 Oct; 206(5):379-382. PubMed ID: 28815296
[TBL] [Abstract][Full Text] [Related]
4. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.
Stinton LM; Myers RP; Coffin CS; Fritzler MJ
BMC Gastroenterol; 2013 Mar; 13():50. PubMed ID: 23506439
[TBL] [Abstract][Full Text] [Related]
5. Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
World J Gastroenterol; 2016 Feb; 22(6):1966-74. PubMed ID: 26877604
[TBL] [Abstract][Full Text] [Related]
6. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
Keppeke GD; Satoh M; Ferraz ML; Chan EK; Andrade LE
Immunol Res; 2014 Oct; 60(1):38-49. PubMed ID: 24845459
[TBL] [Abstract][Full Text] [Related]
7. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.
Carcamo WC; Ceribelli A; Calise SJ; Krueger C; Liu C; Daves M; Villalta D; Bizzaro N; Satoh M; Chan EK
J Clin Immunol; 2013 Feb; 33(2):420-6. PubMed ID: 23100146
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.
Radzimski C; Probst C; Teegen B; Rentzsch K; Blöcker IM; Dähnrich C; Schlumberger W; Stöcker W; Bogdanos DP; Komorowski L
Clin Dev Immunol; 2013; 2013():572815. PubMed ID: 23401700
[TBL] [Abstract][Full Text] [Related]
9. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
J Genet Genomics; 2015 Jun; 42(6):287-99. PubMed ID: 26165495
[TBL] [Abstract][Full Text] [Related]
10. Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
Novembrino C; Aghemo A; Ferraris Fusarini C; Maiavacca R; Matinato C; Lunghi G; Torresani E; Ronchi M; Garlaschi MC; Ramondetta M; Colombo M
J Viral Hepat; 2014 Dec; 21(12):944-9. PubMed ID: 25040504
[TBL] [Abstract][Full Text] [Related]
11. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.
Dähnrich C; Komorowski L; Probst C; Seitz-Polski B; Esnault V; Wetzels JF; Hofstra JM; Hoxha E; Stahl RA; Lambeau G; Stöcker W; Schlumberger W
Clin Chim Acta; 2013 Jun; 421():213-8. PubMed ID: 23541686
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
13. Anti-rods/rings: a human model of drug-induced autoantibody generation.
Calise SJ; Keppeke GD; Andrade LE; Chan EK
Front Immunol; 2015; 6():41. PubMed ID: 25699057
[TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
[TBL] [Abstract][Full Text] [Related]
15. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
16. Molecular cell biology and immunobiology of mammalian rod/ring structures.
Carcamo WC; Calise SJ; von Mühlen CA; Satoh M; Chan EK
Int Rev Cell Mol Biol; 2014; 308():35-74. PubMed ID: 24411169
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructure of cytoplasmic and nuclear inosine-5'-monophosphate dehydrogenase 2 "rods and rings" inclusions.
Juda P; Smigová J; Kováčik L; Bártová E; Raška I
J Histochem Cytochem; 2014 Oct; 62(10):739-50. PubMed ID: 24980853
[TBL] [Abstract][Full Text] [Related]
18. 'Actin-reactive' discriminated from 'non-actin-reactive' smooth muscle autoantibody by immunofluorescence reactivity with rat epithelial cell line.
Toh BH; Taylor R; Pollock W; Dearden S; Gill CC; Buchner C; Burlingame RW
Pathology; 2010; 42(5):463-9. PubMed ID: 20632824
[TBL] [Abstract][Full Text] [Related]
19. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
20. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]